Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 284 entries
Sorted by: Best Match Show Resources per page
Pre-operative Embolization of Primary and Secondary Bone Tumours is Safe and Effective: a Retrospective Study.

World journal of oncology

Al-Hadithy N, Gikas P, Perera J, Aston W, Pollock R, Skinner J, Lotzof K, Cannon S, Briggs TW.
PMID: 29147270
World J Oncol. 2011 Dec;2(6):319-322. doi: 10.4021/wjon389w. Epub 2011 Dec 19.

BACKGROUND: The surgical treatment of bone tumours can result in large peri-operative blood loss, due to their large sizes and hypervascularity. Pre-operative embolisation has been successfully used to downgrade vascularity, thus reducing peri-operative blood loss and its associated complications.METHODS:...

Cite
Al-Hadithy N, Gikas P, Perera J, et al. Pre-operative Embolization of Primary and Secondary Bone Tumours is Safe and Effective: a Retrospective Study. World J Oncol. 2011;2(6):319-322doi: 10.4021/wjon389w.
Al-Hadithy, N., Gikas, P., Perera, J., Aston, W., Pollock, R., Skinner, J., Lotzof, K., Cannon, S., & Briggs, T. W. (2011). Pre-operative Embolization of Primary and Secondary Bone Tumours is Safe and Effective: a Retrospective Study. World journal of oncology, 2(6), 319-322. https://doi.org/10.4021/wjon389w
Al-Hadithy, Nawfal, et al. "Pre-operative Embolization of Primary and Secondary Bone Tumours is Safe and Effective: a Retrospective Study." World journal of oncology vol. 2,6 (2011): 319-322. doi: https://doi.org/10.4021/wjon389w
Al-Hadithy N, Gikas P, Perera J, Aston W, Pollock R, Skinner J, Lotzof K, Cannon S, Briggs TW. Pre-operative Embolization of Primary and Secondary Bone Tumours is Safe and Effective: a Retrospective Study. World J Oncol. 2011 Dec;2(6):319-322. doi: 10.4021/wjon389w. Epub 2011 Dec 19. PMID: 29147270; PMCID: PMC5649719.
Copy Download .nbib Format: NLM
Therapeutic drug monitoring in inflammatory bowel disease: too little too early?-comments on the American Gastroenterology Association Guideline.

Translational gastroenterology and hepatology

Su HY, Ward MG, Sparrow MP.
PMID: 29354770
Transl Gastroenterol Hepatol. 2017 Dec 19;2:113. doi: 10.21037/tgh.2017.12.05. eCollection 2017.

No abstract available.

Cite
Su HY, Ward MG, Sparrow MP. Therapeutic drug monitoring in inflammatory bowel disease: too little too early?-comments on the American Gastroenterology Association Guideline. Transl Gastroenterol Hepatol. 2017;2:113doi: 10.21037/tgh.2017.12.05.
Su, H. Y., Ward, M. G., & Sparrow, M. P. (2017). Therapeutic drug monitoring in inflammatory bowel disease: too little too early?-comments on the American Gastroenterology Association Guideline. Translational gastroenterology and hepatology, 2113. https://doi.org/10.21037/tgh.2017.12.05
Su, Heidi Y, et al. "Therapeutic drug monitoring in inflammatory bowel disease: too little too early?-comments on the American Gastroenterology Association Guideline." Translational gastroenterology and hepatology vol. 2 (2017): 113. doi: https://doi.org/10.21037/tgh.2017.12.05
Su HY, Ward MG, Sparrow MP. Therapeutic drug monitoring in inflammatory bowel disease: too little too early?-comments on the American Gastroenterology Association Guideline. Transl Gastroenterol Hepatol. 2017 Dec 19;2:113. doi: 10.21037/tgh.2017.12.05. eCollection 2017. PMID: 29354770; PMCID: PMC5763035.
Copy Download .nbib Format: NLM
Corrigendum to "DJ-1 can form β-sheet structured aggregates that co-localize with pathological amyloid deposits". Neurobiology of Disease 134 (2020) 104629.

Neurobiology of disease

Solti K, Kuan WL, Fórizs B, Kustos G, Mihály J, Varga Z, Herberth B, Moravcsik É, Kiss R, Kárpáti M, Mikes A, Zhao Y, Imre T, Rochet JC, Aigbirhio F, Williams-Gray CH, Barker RA, Tóth G.
PMID: 32576487
Neurobiol Dis. 2020 Aug;142:104971. doi: 10.1016/j.nbd.2020.104971. Epub 2020 Jun 20.

No abstract available.

Cite
Solti K, Kuan WL, Fórizs B, et al. Corrigendum to "DJ-1 can form β-sheet structured aggregates that co-localize with pathological amyloid deposits". Neurobiology of Disease 134 (2020) 104629. Neurobiol Dis. 2020;142:104971doi: 10.1016/j.nbd.2020.104971.
Solti, K., Kuan, W. L., Fórizs, B., Kustos, G., Mihály, J., Varga, Z., Herberth, B., Moravcsik, �. �., Kiss, R., Kárpáti, M., Mikes, A., Zhao, Y., Imre, T., Rochet, J. C., Aigbirhio, F., Williams-Gray, C. H., Barker, R. A., & Tóth, G. (2020). Corrigendum to "DJ-1 can form β-sheet structured aggregates that co-localize with pathological amyloid deposits". Neurobiology of Disease 134 (2020) 104629. Neurobiology of disease, 142104971. https://doi.org/10.1016/j.nbd.2020.104971
Solti, Katalin, et al. "Corrigendum to "DJ-1 can form β-sheet structured aggregates that co-localize with pathological amyloid deposits". Neurobiology of Disease 134 (2020) 104629." Neurobiology of disease vol. 142 (2020): 104971. doi: https://doi.org/10.1016/j.nbd.2020.104971
Solti K, Kuan WL, Fórizs B, Kustos G, Mihály J, Varga Z, Herberth B, Moravcsik É, Kiss R, Kárpáti M, Mikes A, Zhao Y, Imre T, Rochet JC, Aigbirhio F, Williams-Gray CH, Barker RA, Tóth G. Corrigendum to "DJ-1 can form β-sheet structured aggregates that co-localize with pathological amyloid deposits". Neurobiology of Disease 134 (2020) 104629. Neurobiol Dis. 2020 Aug;142:104971. doi: 10.1016/j.nbd.2020.104971. Epub 2020 Jun 20. PMID: 32576487.
Copy Download .nbib Format: NLM
SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection.

medRxiv : the preprint server for health sciences

Cele S, Jackson L, Khan K, Khoury DS, Moyo-Gwete T, Tegally H, Scheepers C, Amoako D, Karim F, Bernstein M, Lustig G, Archary D, Smith M, Ganga Y, Jule Z, Reedoy K, Cromer D, San JE, Hwa SH, Giandhari J, Blackburn JM, Gosnell BI, Karim SSA, Hanekom W, von Gottberg A, Bhiman J, Lessells RJ, Moosa MS, Davenport MP, de Oliveira T, Moore PL, Sigal A.
PMID: 34909788
medRxiv. 2021 Dec 11; doi: 10.1101/2021.12.08.21267417.

The emergence of the SARS-CoV-2 Omicron variant, first identified in South Africa, may compromise the ability of vaccine and previous infection (1) elicited immunity to protect against new infection. Here we investigated whether Omicron escapes antibody neutralization elicited by...

Cite
Cele S, Jackson L, Khan K, et al. SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection. medRxiv. 2021;doi: 10.1101/2021.12.08.21267417.
Cele, S., Jackson, L., Khan, K., Khoury, D. S., Moyo-Gwete, T., Tegally, H., Scheepers, C., Amoako, D., Karim, F., Bernstein, M., Lustig, G., Archary, D., Smith, M., Ganga, Y., Jule, Z., Reedoy, K., Cromer, D., San, J. E., Hwa, S. H., Giandhari, J., Blackburn, J. M., Gosnell, B. I., Karim, S. S. A., Hanekom, W., von Gottberg, A., Bhiman, J., Lessells, R. J., Moosa, M. S., Davenport, M. P., de Oliveira, T., Moore, P. L., & Sigal, A. (2021). SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2021.12.08.21267417
Cele, Sandile, et al. "SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection." medRxiv : the preprint server for health sciences vol. (2021). doi: https://doi.org/10.1101/2021.12.08.21267417
Cele S, Jackson L, Khan K, Khoury DS, Moyo-Gwete T, Tegally H, Scheepers C, Amoako D, Karim F, Bernstein M, Lustig G, Archary D, Smith M, Ganga Y, Jule Z, Reedoy K, Cromer D, San JE, Hwa SH, Giandhari J, Blackburn JM, Gosnell BI, Karim SSA, Hanekom W, von Gottberg A, Bhiman J, Lessells RJ, Moosa MS, Davenport MP, de Oliveira T, Moore PL, Sigal A. SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection. medRxiv. 2021 Dec 11; doi: 10.1101/2021.12.08.21267417. PMID: 34909788; PMCID: PMC8669855.
Copy Download .nbib Format: NLM
The Genetic Architecture of Bovine Telomere Length in Early Life and Association With Animal Fitness.

Frontiers in genetics

Ilska-Warner JJ, Psifidi A, Seeker LA, Wilbourn RV, Underwood SL, Fairlie J, Whitelaw B, Nussey DH, Coffey MP, Banos G.
PMID: 31749836
Front Genet. 2019 Oct 25;10:1048. doi: 10.3389/fgene.2019.01048. eCollection 2019.

Health and survival are key goals for selective breeding in farm animals. Progress, however, is often limited by the low heritability of these animal fitness traits in addition to measurement difficulties. In this respect, relevant early-life biomarkers may be...

Cite
Ilska-Warner JJ, Psifidi A, Seeker LA, et al. The Genetic Architecture of Bovine Telomere Length in Early Life and Association With Animal Fitness. Front Genet. 2019;10:1048doi: 10.3389/fgene.2019.01048.
Ilska-Warner, J. J., Psifidi, A., Seeker, L. A., Wilbourn, R. V., Underwood, S. L., Fairlie, J., Whitelaw, B., Nussey, D. H., Coffey, M. P., & Banos, G. (2019). The Genetic Architecture of Bovine Telomere Length in Early Life and Association With Animal Fitness. Frontiers in genetics, 101048. https://doi.org/10.3389/fgene.2019.01048
Ilska-Warner, Joanna J, et al. "The Genetic Architecture of Bovine Telomere Length in Early Life and Association With Animal Fitness." Frontiers in genetics vol. 10 (2019): 1048. doi: https://doi.org/10.3389/fgene.2019.01048
Ilska-Warner JJ, Psifidi A, Seeker LA, Wilbourn RV, Underwood SL, Fairlie J, Whitelaw B, Nussey DH, Coffey MP, Banos G. The Genetic Architecture of Bovine Telomere Length in Early Life and Association With Animal Fitness. Front Genet. 2019 Oct 25;10:1048. doi: 10.3389/fgene.2019.01048. eCollection 2019. PMID: 31749836; PMCID: PMC6843005.
Copy Download .nbib Format: NLM
Bioconversion of lignin-derived aromatics into the building block pyridine 2,4-dicarboxylic acid by engineering recombinant Pseudomonas putida strains.

Bioresource technology

Gómez-Álvarez H, Iturbe P, Rivero-Buceta V, Mines P, Bugg TDH, Nogales J, Díaz E.
PMID: 34971782
Bioresour Technol. 2021 Dec 28;346:126638. doi: 10.1016/j.biortech.2021.126638. Epub 2021 Dec 28.

2,4 pyridine dicarboxylic acid (2,4 PDCA) is an analogue of terephthalate, and hence a target chemical in the field of bio-based plastics. Here, Pseudomonas putida KT2440 strains were engineered to efficiently drive the metabolism of lignin-derived monoaromatics towards 2,4...

Cite
Gómez-Álvarez H, Iturbe P, Rivero-Buceta V, et al. Bioconversion of lignin-derived aromatics into the building block pyridine 2,4-dicarboxylic acid by engineering recombinant Pseudomonas putida strains. Bioresour Technol. 2021;346:126638doi: 10.1016/j.biortech.2021.126638.
Gómez-Álvarez, H., Iturbe, P., Rivero-Buceta, V., Mines, P., Bugg, T. D. H., Nogales, J., & Díaz, E. (2021). Bioconversion of lignin-derived aromatics into the building block pyridine 2,4-dicarboxylic acid by engineering recombinant Pseudomonas putida strains. Bioresource technology, 346126638. https://doi.org/10.1016/j.biortech.2021.126638
Gómez-Álvarez, Helena, et al. "Bioconversion of lignin-derived aromatics into the building block pyridine 2,4-dicarboxylic acid by engineering recombinant Pseudomonas putida strains." Bioresource technology vol. 346 (2021): 126638. doi: https://doi.org/10.1016/j.biortech.2021.126638
Gómez-Álvarez H, Iturbe P, Rivero-Buceta V, Mines P, Bugg TDH, Nogales J, Díaz E. Bioconversion of lignin-derived aromatics into the building block pyridine 2,4-dicarboxylic acid by engineering recombinant Pseudomonas putida strains. Bioresour Technol. 2021 Dec 28;346:126638. doi: 10.1016/j.biortech.2021.126638. Epub 2021 Dec 28. PMID: 34971782.
Copy Download .nbib Format: NLM
Use of allopurinol to optimize thiopurine immunomodulator efficacy in inflammatory bowel disease.

Gastroenterology & hepatology

Sparrow MP.
PMID: 21960930
Gastroenterol Hepatol (N Y). 2008 Jul;4(7):505-11.

The thiopurine immunomodulators azathioprine and 6-mercaptopurine are integral to the management of inflammatory bowel disease (IBD), particularly as corticosteroid-sparing and maintenance agents; however, up to 50% of patients do not adequately respond to these agents. Advances in pharmacogenomics and...

Cite
Sparrow MP. Use of allopurinol to optimize thiopurine immunomodulator efficacy in inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2008;4(7):505-11
Sparrow, M. P. (2008). Use of allopurinol to optimize thiopurine immunomodulator efficacy in inflammatory bowel disease. Gastroenterology & hepatology, 4(7), 505-11.
Sparrow, Miles P. "Use of allopurinol to optimize thiopurine immunomodulator efficacy in inflammatory bowel disease." Gastroenterology & hepatology vol. 4,7 (2008): 505-11.
Sparrow MP. Use of allopurinol to optimize thiopurine immunomodulator efficacy in inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2008 Jul;4(7):505-11. PMID: 21960930; PMCID: PMC3096137.
Copy Download .nbib Format: NLM
Surfactants and the skin.

International journal of cosmetic science

Dykes P.
PMID: 18505489
Int J Cosmet Sci. 1998 Feb;20(1):53-61. doi: 10.1046/j.1467-2494.1998.171735.x.

The skin surface is the interface between us, the organism, and the outside world. When we clean the skin we remove not only the bacteria, dirt and grease which have accumulated, but also part of our natural barrier -...

Cite
Dykes P. Surfactants and the skin. Int J Cosmet Sci. 1998;20(1):53-61doi: 10.1046/j.1467-2494.1998.171735.x.
Dykes, P. (1998). Surfactants and the skin. International journal of cosmetic science, 20(1), 53-61. https://doi.org/10.1046/j.1467-2494.1998.171735.x
Dykes, P. "Surfactants and the skin." International journal of cosmetic science vol. 20,1 (1998): 53-61. doi: https://doi.org/10.1046/j.1467-2494.1998.171735.x
Dykes P. Surfactants and the skin. Int J Cosmet Sci. 1998 Feb;20(1):53-61. doi: 10.1046/j.1467-2494.1998.171735.x. PMID: 18505489.
Copy Download .nbib Format: NLM
A Single Educational Intervention Improves Pregnancy-Related Knowledge and Emotional Health Among Women With IBD Who Are Pregnant or Wish to Conceive.

Inflammatory bowel diseases

Flanagan E, Wright EK, Sparrow MP, Moore GT, Connell WR, De Cruz P, Christensen B, Shelton E, Kamm MA, Ward MG, Dowling D, Brown S, Kashkooli S, Thompson AJ, Ross AL, Kiburg KV, Bell SJ.
PMID: 33704467
Inflamm Bowel Dis. 2021 Nov 15;27(12):1909-1918. doi: 10.1093/ibd/izab021.

BACKGROUND: There is considerable interest in improving the education and care of women with inflammatory bowel disease (IBD) to improve pregnancy outcomes. Despite increased awareness, not all women with IBD have access to pregnancy-related education and the quality of...

Cite
Flanagan E, Wright EK, Sparrow MP, et al. A Single Educational Intervention Improves Pregnancy-Related Knowledge and Emotional Health Among Women With IBD Who Are Pregnant or Wish to Conceive. Inflamm Bowel Dis. 2021;27(12):1909-1918doi: 10.1093/ibd/izab021.
Flanagan, E., Wright, E. K., Sparrow, M. P., Moore, G. T., Connell, W. R., De Cruz, P., Christensen, B., Shelton, E., Kamm, M. A., Ward, M. G., Dowling, D., Brown, S., Kashkooli, S., Thompson, A. J., Ross, A. L., Kiburg, K. V., & Bell, S. J. (2021). A Single Educational Intervention Improves Pregnancy-Related Knowledge and Emotional Health Among Women With IBD Who Are Pregnant or Wish to Conceive. Inflammatory bowel diseases, 27(12), 1909-1918. https://doi.org/10.1093/ibd/izab021
Flanagan, Emma, et al. "A Single Educational Intervention Improves Pregnancy-Related Knowledge and Emotional Health Among Women With IBD Who Are Pregnant or Wish to Conceive." Inflammatory bowel diseases vol. 27,12 (2021): 1909-1918. doi: https://doi.org/10.1093/ibd/izab021
Flanagan E, Wright EK, Sparrow MP, Moore GT, Connell WR, De Cruz P, Christensen B, Shelton E, Kamm MA, Ward MG, Dowling D, Brown S, Kashkooli S, Thompson AJ, Ross AL, Kiburg KV, Bell SJ. A Single Educational Intervention Improves Pregnancy-Related Knowledge and Emotional Health Among Women With IBD Who Are Pregnant or Wish to Conceive. Inflamm Bowel Dis. 2021 Nov 15;27(12):1909-1918. doi: 10.1093/ibd/izab021. PMID: 33704467.
Copy Download .nbib Format: NLM
Current Controversies in Crohn's Disease: A Roundtable Discussion of the BRIDGe Group.

Gastroenterology & hepatology

Sparrow MP, Irving PM, Baidoo L, Bressler B, Cheifetz AS, Devlin SM, Harrell LE, Jones J, Kozuch PL, Melmed GY, Velayos FS, Siegel CA.
PMID: 21960891
Gastroenterol Hepatol (N Y). 2008 Oct;4(10):713-20.

In March 2008, a roundtable discussion was convened by the inflammatory bowel disease (IBD) specialist panel the BRIDGe (Building Resources and Research in IBD Globally) group, which consists of junior faculty gastroenterologists who have undergone advanced fellowship training at...

Cite
Sparrow MP, Irving PM, Baidoo L, et al. Current Controversies in Crohn's Disease: A Roundtable Discussion of the BRIDGe Group. Gastroenterol Hepatol (N Y). 2008;4(10):713-20
Sparrow, M. P., Irving, P. M., Baidoo, L., Bressler, B., Cheifetz, A. S., Devlin, S. M., Harrell, L. E., Jones, J., Kozuch, P. L., Melmed, G. Y., Velayos, F. S., & Siegel, C. A. (2008). Current Controversies in Crohn's Disease: A Roundtable Discussion of the BRIDGe Group. Gastroenterology & hepatology, 4(10), 713-20.
Sparrow, Miles P, et al. "Current Controversies in Crohn's Disease: A Roundtable Discussion of the BRIDGe Group." Gastroenterology & hepatology vol. 4,10 (2008): 713-20.
Sparrow MP, Irving PM, Baidoo L, Bressler B, Cheifetz AS, Devlin SM, Harrell LE, Jones J, Kozuch PL, Melmed GY, Velayos FS, Siegel CA. Current Controversies in Crohn's Disease: A Roundtable Discussion of the BRIDGe Group. Gastroenterol Hepatol (N Y). 2008 Oct;4(10):713-20. PMID: 21960891; PMCID: PMC3104182.
Copy Download .nbib Format: NLM
The Effect of Bacillus thuringiensis M-exotoxin on Trematode Cercariae.

Journal of invertebrate pathology

Horak P, Weiser J, Mikes L, Kolarova L.
PMID: 8812565
J Invertebr Pathol. 1996 Jul;68(1):41-9. doi: 10.1006/jipa.1996.0056.

The effect of Bacillus thuringiensis israelensis eluate containing water-soluble exotoxin (M-exotoxin) was observed by its use on cercariae of seven trematode species. To the most sensitive species to the toxic effect of the mentioned toxin belonged schistosome furcocercariae (human...

Cite
Horak P, Weiser J, Mikes L, et al. The Effect of Bacillus thuringiensis M-exotoxin on Trematode Cercariae. J Invertebr Pathol. 1996;68(1):41-9doi: 10.1006/jipa.1996.0056.
Horak, P., Weiser, J., Mikes, L., & Kolarova, L. (1996). The Effect of Bacillus thuringiensis M-exotoxin on Trematode Cercariae. Journal of invertebrate pathology, 68(1), 41-9. https://doi.org/10.1006/jipa.1996.0056
Horak, et al. "The Effect of Bacillus thuringiensis M-exotoxin on Trematode Cercariae." Journal of invertebrate pathology vol. 68,1 (1996): 41-9. doi: https://doi.org/10.1006/jipa.1996.0056
Horak P, Weiser J, Mikes L, Kolarova L. The Effect of Bacillus thuringiensis M-exotoxin on Trematode Cercariae. J Invertebr Pathol. 1996 Jul;68(1):41-9. doi: 10.1006/jipa.1996.0056. PMID: 8812565.
Copy Download .nbib Format: NLM
Hyperkalemia influences the outcome of patients with cirrhosis with acute decompensation (AD) and acute-on-chronic liver failure (ACLF).

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Mezzano G, Cárdenas A, Aguilar F, Pavesi M, Solé C, Napoleone L, Graupera I, Juanola A, Carol M, Pose E, Fabrellas N, Hernaez R, Martínez J, Saliba F, Arroyo V, Sola E, Gines P.
PMID: 33446445
Dig Liver Dis. 2021 Jun;53(6):738-745. doi: 10.1016/j.dld.2020.12.009. Epub 2021 Jan 11.

INTRODUCTION: The presence of hyperkalemia in different clinical scenarios has been described as a risk factor for mortality. Information about this electrolyte disorder in patients with cirrhosis is limited and there are no data in patients with acute-on-chronic liver...

Cite
Mezzano G, Cárdenas A, Aguilar F, et al. Hyperkalemia influences the outcome of patients with cirrhosis with acute decompensation (AD) and acute-on-chronic liver failure (ACLF). Dig Liver Dis. 2021;53(6):738-745doi: 10.1016/j.dld.2020.12.009.
Mezzano, G., Cárdenas, A., Aguilar, F., Pavesi, M., Solé, C., Napoleone, L., Graupera, I., Juanola, A., Carol, M., Pose, E., Fabrellas, N., Hernaez, R., Martínez, J., Saliba, F., Arroyo, V., Sola, E., & Gines, P. (2021). Hyperkalemia influences the outcome of patients with cirrhosis with acute decompensation (AD) and acute-on-chronic liver failure (ACLF). Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 53(6), 738-745. https://doi.org/10.1016/j.dld.2020.12.009
Mezzano, Gabriel, et al. "Hyperkalemia influences the outcome of patients with cirrhosis with acute decompensation (AD) and acute-on-chronic liver failure (ACLF)." Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver vol. 53,6 (2021): 738-745. doi: https://doi.org/10.1016/j.dld.2020.12.009
Mezzano G, Cárdenas A, Aguilar F, Pavesi M, Solé C, Napoleone L, Graupera I, Juanola A, Carol M, Pose E, Fabrellas N, Hernaez R, Martínez J, Saliba F, Arroyo V, Sola E, Gines P. Hyperkalemia influences the outcome of patients with cirrhosis with acute decompensation (AD) and acute-on-chronic liver failure (ACLF). Dig Liver Dis. 2021 Jun;53(6):738-745. doi: 10.1016/j.dld.2020.12.009. Epub 2021 Jan 11. PMID: 33446445.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 284 entries